| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Zuddas, G Oberto, F Vaglini, F Fascetti, F Fornai, G U Corsin. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. Journal of neurochemistry. vol 59. issue 2. 1992-08-20. PMID:1629743. |
mk-801 also attenuated dopamine depletion in the caudate and putamen and protected dopaminergic neurons in the substantia nigra from the degeneration induced by the neurotoxin. |
1992-08-20 |
2023-08-11 |
monkey |
| D G Kirch, T R Taylor, I Creese, S X Xu, R J Wyat. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors. The Journal of pharmacy and pharmacology. vol 44. issue 2. 1992-08-19. PMID:1352822. |
although nicotine has been shown to affect nigrostriatal dopamine release, chronic treatment does not appear to alter overall striatal dopaminergic receptor binding parameters. |
1992-08-19 |
2023-08-11 |
rat |
| M F Casanova, S O Comparini, R W Kim, J E Kleinma. Staining intensity of brain iron in patients with schizophrenia: a postmortem study. The Journal of neuropsychiatry and clinical neurosciences. vol 4. issue 1. 1992-08-19. PMID:1627959. |
evidence derived from both pharmacological and postmortem studies suggests that a disturbance of brain iron metabolism is involved in the pathophysiology of schizophrenia; i.e., the distribution of iron parallels that of dopamine, and variations in its brain concentration selectively modulate the binding affinity of the dopaminergic (d2) receptor. |
1992-08-19 |
2023-08-11 |
Not clear |
| I J Mitchell, S Boyce, M A Sambrook, A R Crossma. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain : a journal of neurology. vol 115 ( Pt 3). 1992-08-19. PMID:1628204. |
the remaining animals spent an equivalent period of time relatively unexposed to dopaminergic agents, receiving only therapeutic doses, and at no time showed any signs of dopamine agonist-induced dyskinesia. |
1992-08-19 |
2023-08-11 |
monkey |
| K A Gary, B M Chronwal. The onset of dopaminergic innervation during ontogeny decreases melanotrope proliferation in the intermediate lobe of the rat pituitary. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. vol 10. issue 2. 1992-08-18. PMID:1352934. |
the onset of innervation and increased dopamine concentration suggests increased dopaminergic control of the melanotropes, illustrated specifically by a decrease in their level of proliferation. |
1992-08-18 |
2023-08-11 |
rat |
| J A Skrinskaya, E M Nikulina, N K Popov. Role of genotype in brain dopamine metabolism and dopamine-dependent behavior of mice. Pharmacology, biochemistry, and behavior. vol 42. issue 2. 1992-08-17. PMID:1385878. |
in mice of eight inbred strains--balb/c, akr/j, dba/2, cba, c57b1/6, dd, cc57br, and c3h/he--brain dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid (dopac) and homovanillic acid (hva), in striatum and nucleus accumbens with tuberculum olfactorium, the structures of two main dopaminergic systems--nigrostriatal and mesolimbic--were determined. |
1992-08-17 |
2023-08-11 |
mouse |
| J A Skrinskaya, E M Nikulina, N K Popov. Role of genotype in brain dopamine metabolism and dopamine-dependent behavior of mice. Pharmacology, biochemistry, and behavior. vol 42. issue 2. 1992-08-17. PMID:1385878. |
in both dopaminergic regions, no strain effect on either dopamine or dopac levels was found, while for hva content a highly significant hereditary determination was shown. |
1992-08-17 |
2023-08-11 |
mouse |
| D L Rosin, W A Clark, M Goldstein, R H Roth, A Y Deutc. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. vol 48. issue 4. 1992-08-14. PMID:1352864. |
6-hydroxydopamine lesions of the dopaminergic innervation of the prefrontal cortex did not alter concentrations of dopamine or its metabolite 3,4-dihydroxyphenylacetic acid in either the striatum or nucleus accumbens. |
1992-08-14 |
2023-08-11 |
human |
| D L Rosin, W A Clark, M Goldstein, R H Roth, A Y Deutc. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. vol 48. issue 4. 1992-08-14. PMID:1352864. |
these data suggest that lesions of the prefrontal cortical dopamine innervation do not result in significant alterations in basal dopaminergic function in the striatal complex. |
1992-08-14 |
2023-08-11 |
human |
| D L Rosin, W A Clark, M Goldstein, R H Roth, A Y Deutc. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience. vol 48. issue 4. 1992-08-14. PMID:1352864. |
however, lesions of the dopaminergic innervation of the prefrontal cortex significantly increase the responsiveness of mesolimbic dopamine afferents to pharmacological challenge. |
1992-08-14 |
2023-08-11 |
human |
| U M Schrell, P Nomikos, R Fahlbusc. Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. Journal of neurosurgery. vol 77. issue 2. 1992-08-13. PMID:1385626. |
competition curves reveal the presence of a dopamine d1 receptor by rank order of various dopaminergic and nondopaminergic antagonists ((+)-sch-23390 greater than (+/-)-skf-83566 greater than (cis)-flupentixol greater than (+)-butaclamol greater than chlorpromazine greater than 1-sulpiride greater than mianserin greater than (-)-butaclamol). |
1992-08-13 |
2023-08-11 |
human |
| D Zieba, T Wegrzyn, E Cebrat, Z Leroc. [Effect of dopamine on cecum motility in sheep]. Polskie archiwum weterynaryjne. vol 31. issue 1-2. 1992-08-13. PMID:1821029. |
it has been concluded that dopamine inhibits the caecum motility in sheep through specific dopaminergic receptors. |
1992-08-13 |
2023-08-11 |
Not clear |
| P Mitchell, L Selbie, B Waters, J Donald, C Vivero, M Tully, J Shin. Exclusion of close linkage of bipolar disorder to dopamine D1 and D2 receptor gene markers. Journal of affective disorders. vol 25. issue 1. 1992-08-11. PMID:1385598. |
a potential role of dopamine in bipolar disorder has been suggested by several strands of evidence, namely the ability of dopaminergic agonists to induce mania and the effects of lithium, carbamazepine and the antipsychotics on central dopamine receptors and/or turnover. |
1992-08-11 |
2023-08-11 |
Not clear |
| S Shimada, S Kitayama, D Walther, G Uh. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain research. Molecular brain research. vol 13. issue 4. 1992-08-10. PMID:1352613. |
different dopaminergic cell groups display different levels of dat1 dopamine transporter expression. |
1992-08-10 |
2023-08-11 |
Not clear |
| R J Baldessarini, E R Marsh, N S Kul. Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain research. vol 579. issue 1. 1992-08-10. PMID:1623401. |
given evidence of inhibitory effects of serotonin on dopaminergic neurotransmission, a series of experiments sought neurochemical evidence of interactions between the selective serotonin transport inhibitor fluoxetine and the metabolism of dopamine (da) or serotonin (5-ht) in regions of rat brain that might account for extrapyramidal side-effects associated with clinical use of fluoxetine. |
1992-08-10 |
2023-08-11 |
rat |
| A Bidzseranova, J Gueron, G Tóth, B Penke, G Telegd. Effect of atrial natriuretic peptide on apomorphine-induced stereotyped cage-climbing behavior in mice. European journal of pharmacology. vol 211. issue 3. 1992-08-06. PMID:1352255. |
since cage-climbing behavior is described as a simple test for studying dopaminergic activity in the central nervous system, a systemic study was carried out with anp-(1-28) in order to confirm or to exclude the possible involvement of dopamine in the anp-induced action in the brain. |
1992-08-06 |
2023-08-11 |
mouse |
| A Bidzseranova, J Gueron, G Tóth, B Penke, G Telegd. Effect of atrial natriuretic peptide on apomorphine-induced stereotyped cage-climbing behavior in mice. European journal of pharmacology. vol 211. issue 3. 1992-08-06. PMID:1352255. |
these data suggest that anp might be regarded as a dopamine agonist-modulating agent and that a dopaminergic mechanism is a possible mode of action of anp in the fear-induced learning studied earlier. |
1992-08-06 |
2023-08-11 |
mouse |
| E Toth, H Sershen, A Hashim, E S Vizi, A Lajth. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochemical research. vol 17. issue 3. 1992-08-05. PMID:1352387. |
the cholinergic antagonists mecamylamine and atropine, the dopaminergic antagonists haloperidol and sulpiride, and the excitatory amino acid antagonist kynurenic acid all inhibited the nicotine-induced increase of extracellular dopamine in the striatum. |
1992-08-05 |
2023-08-11 |
rat |
| M R Zarrindast, S A Tabataba. Involvement of dopamine receptor subtypes in mouse thermoregulation. Psychopharmacology. vol 107. issue 2-3. 1992-07-30. PMID:1535446. |
it is concluded that the presynaptic dopamine neurons are involved in hypothermia, while both postsynaptic d-1 and d-2 dopamine receptors may mediated the hyperthermia induced by dopaminergic agents. |
1992-07-30 |
2023-08-11 |
mouse |
| D J Heal, A T Frankland, J Gosden, L J Hutchins, M R Prow, G P Luscombe, W R Bucket. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. Psychopharmacology. vol 107. issue 2-3. 1992-07-30. PMID:1615130. |
a comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. |
1992-07-30 |
2023-08-11 |
rat |